Dedicare AB
Dedicare AB (publ) operates as a recruitment and staffing company in the healthcare, life science, education, and social work industries in Sweden, Norway, Finland, the United Kingdom, and Denmark. It recruits and contracts doctors and nurses; social secretaries, family therapists, curators and family home consultants, psychologists, and various support services in psychosocial work; educators, a… Read more
Dedicare AB (0P3K) - Net Assets
Latest net assets as of September 2021: Skr159.80 Million SEK
Based on the latest financial reports, Dedicare AB (0P3K) has net assets worth Skr159.80 Million SEK as of September 2021.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (Skr452.80 Million) and total liabilities (Skr293.00 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | Skr159.80 Million |
| % of Total Assets | 35.29% |
| Annual Growth Rate | 2.71% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 23.43 |
Dedicare AB - Net Assets Trend (2016–2020)
This chart illustrates how Dedicare AB's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Dedicare AB (2016–2020)
The table below shows the annual net assets of Dedicare AB from 2016 to 2020.
| Year | Net Assets | Change |
|---|---|---|
| 2020-12-31 | Skr135.42 Million | +45.48% |
| 2019-12-31 | Skr93.09 Million | -9.14% |
| 2018-12-31 | Skr102.45 Million | -6.40% |
| 2017-12-31 | Skr109.46 Million | -10.05% |
| 2016-12-31 | Skr121.69 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Dedicare AB's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 5.6% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2020)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | Skr128.76 Million | 95.08% |
| Common Stock | Skr4.70 Million | 3.47% |
| Other Components | Skr1.96 Million | 1.45% |
| Total Equity | Skr135.42 Million | 100.00% |
Dedicare AB Competitors by Market Cap
The table below lists competitors of Dedicare AB ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Chander Electronics Corp.
TWO:8068
|
$19.87 Million |
|
Prime Financial Group Ltd
AU:PFG
|
$19.88 Million |
|
Shane Global Holding Inc
TW:8482
|
$19.89 Million |
|
Battery Minerals Limited
PINK:BTRYF
|
$19.90 Million |
|
Nova EYE Medical Ltd
AU:EYE
|
$19.87 Million |
|
Biohit Oyj B
HE:BIOBV
|
$19.87 Million |
|
Buriram Sugar Public Company Limited
BK:BRR
|
$19.86 Million |
|
Elauwit Connection, Inc. Common Stock
NASDAQ:ELWT
|
$19.86 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Dedicare AB's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2019 to 2020, total equity changed from 93,088,000 to 135,423,000, a change of 42,335,000 (45.5%).
- Net income of 36,063,000 contributed positively to equity growth.
- Dividend payments of 23,488,000 reduced retained earnings.
- Other factors increased equity by 29,760,000.
Equity Change Factors (2019 to 2020)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | Skr36.06 Million | +26.63% |
| Dividends Paid | Skr23.49 Million | -17.34% |
| Other Changes | Skr29.76 Million | +21.98% |
| Total Change | Skr- | 45.48% |
Book Value vs Market Value Analysis
This analysis compares Dedicare AB's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently Dedicare AB utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 26.63%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 4.07%
- • Asset Turnover: 2.30x
- • Equity Multiplier: 2.84x
- Recent ROE (26.63%) is below the historical average (37.91%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2016 | 43.50% | 8.14% | 2.80x | 1.91x | Skr40.77 Million |
| 2017 | 53.72% | 7.51% | 3.36x | 2.13x | Skr47.85 Million |
| 2018 | 37.32% | 4.71% | 3.76x | 2.11x | Skr27.99 Million |
| 2019 | 28.40% | 3.41% | 3.24x | 2.57x | Skr17.13 Million |
| 2020 | 26.63% | 4.07% | 2.30x | 2.84x | Skr22.52 Million |
Industry Comparison
This section compares Dedicare AB's net assets metrics with peer companies in the same industry.
Industry Context
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Dedicare AB (0P3K) | Skr159.80 Million | 43.50% | 1.83x | $19.87 Million |
| Nyfosa AB (0A0K) | $2.92 Billion | 39.50% | 2.88x | $973.31 Million |
| High Templar Tech Limited (0A2T) | $12.52 Billion | 4.70% | 0.13x | $255.82 Million |
| Strategy Inc (0A7O) | $51.04 Billion | -7.54% | 0.21x | $40.17 Billion |
| NACON SASU (0A9N) | $67.54 Million | 15.85% | 1.20x | $7.64 Million |
| Antin Infrastructure Partners (0AA5) | $23.79 Million | 108.98% | 1.09x | $573.10 Million |
| Truecaller AB Series B (0AA7) | $1.41 Billion | 18.30% | 0.20x | $281.60 Million |
| Brockhaus Technologies AG (0AAW) | $254.92 Million | -6.23% | 1.68x | $74.40 Million |
| Hyloris Pharmaceuticals S.A. (0AB6) | $48.06 Million | -24.09% | 0.32x | $71.96 Million |
| Kalray S.A. (0ABT) | $28.43 Million | -41.56% | 0.67x | $33.84 Million |
| Webuild S.p.A. (0BJP) | $1.43 Billion | 10.29% | 7.14x | $1.13 Billion |